Bookmark
Forward
New Insulins, Biosimilars, and Insulin Therapy.
Thomas Danne, Lutz Heinemann, Jan Bolinder
Diabetes technology & therapeutics 2022 Mar
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Thomas Danne, Lutz Heinemann, Jan Bolinder.
New Insulins, Biosimilars, and Insulin Therapy.
Diabetes technology & therapeutics.
2022 Mar;24(S1):S35-S57
Mesh Tags
Biosimilar Pharmaceuticals
Humans
Insulin
Insulin, Regular, Human
Insulins
Substances
Biosimilar Pharmaceuticals
Insulin
Insulin, Regular, Human
Insulins
PMID: 35475698
View Full Text